Spyglass Capital Management LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spyglass Capital Management LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$33,914,620
+1.1%
831,037
-4.3%
2.56%
-5.1%
Q4 2022$33,539,966
-49.6%
868,686
-30.6%
2.69%
-42.8%
Q3 2022$66,612,000
-21.8%
1,252,342
-14.3%
4.71%
-0.5%
Q2 2022$85,155,000
-40.4%
1,460,634
-21.9%
4.73%
-3.0%
Q1 2022$142,798,000
+12.8%
1,871,040
-11.0%
4.88%
+45.3%
Q4 2021$126,547,000
+2.2%
2,103,165
-4.9%
3.36%
+18.2%
Q3 2021$123,828,000
-3.6%
2,211,210
+4.4%
2.84%
-0.7%
Q2 2021$128,500,000
-7.3%
2,117,673
+7.1%
2.86%
-21.7%
Q1 2021$138,631,000
+17.4%
1,977,897
+0.3%
3.65%
+0.9%
Q4 2020$118,039,000
+8.3%
1,972,570
+8.8%
3.62%
-28.1%
Q3 2020$108,990,000
+35.7%
1,812,877
+18.4%
5.04%
+1.3%
Q2 2020$80,323,000
+101.2%
1,530,831
+28.6%
4.98%
+10.3%
Q1 2020$39,919,000
+2.8%
1,190,537
+38.9%
4.51%
-9.5%
Q4 2019$38,814,000
+123.0%
856,827
+87.4%
4.98%
+7.8%
Q3 2019$17,408,000
+5.4%
457,250
+20.5%
4.62%
-11.4%
Q2 2019$16,509,000
+82.0%
379,609
+59.3%
5.22%
+48.6%
Q1 2019$9,071,000
+75.5%
238,327
+98.3%
3.51%
-9.4%
Q4 2018$5,169,000120,1573.87%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders